Procalcitonin Monitoring Sepsis Study (MOSES)

B·R·A·H·M·S

Status: Completed

Conditions: Severe Sepsis; Septic Shock

Study type: Observational

Funder types: Industry

Identifiers

NCT01523717

brahms-moses

Details and patient eligibility

About

The purpose of this study is to investigate the relationship between a procalcitonin decrease over 72 hours and outcome in patients who have severe sepsis or septic shock.

Enrollment: 858 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Adult patients (i.e. >18 years of age) diagnosed with severe sepsis or septic shock as defined in Appendix 1, who are already in the ICU or come from the ED, other wards or directly from out of hospital
• Blood sample collection within 12 hours after diagnosis "severe sepsis or septic shock"No prior enrollment into this study
• Written informed consent